USD 0.51
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -14.63 Million USD | -14.13% |
2022 | -12.82 Million USD | -94.55% |
2021 | -6.59 Million USD | -389.09% |
2020 | -1.34 Million USD | -73.26% |
2019 | -778 Thousand USD | -101.82% |
2018 | 42.82 Million USD | 368.36% |
2017 | -15.95 Million USD | -129.86% |
2016 | 53.43 Million USD | 619.4% |
2015 | 7.42 Million USD | 175.85% |
2014 | -9.79 Million USD | -33.8% |
2013 | -7.31 Million USD | 40.02% |
2012 | -12.2 Million USD | 80.13% |
2011 | -61.42 Million USD | -209.27% |
2010 | -19.86 Million USD | 3.01% |
2009 | -20.47 Million USD | -322.44% |
2008 | 9.2 Million USD | 2670.72% |
2007 | -358.07 Thousand USD | 95.32% |
2006 | -7.64 Million USD | 33.31% |
2005 | -11.46 Million USD | 45.27% |
2004 | -20.94 Million USD | -65.2% |
2003 | -12.68 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -4.6 Million USD | -18.74% |
2024 Q2 | -4.95 Million USD | -7.6% |
2023 Q3 | -3.47 Million USD | -10.02% |
2023 Q2 | -3.15 Million USD | 23.37% |
2023 Q4 | -3.87 Million USD | -11.79% |
2023 FY | -14.63 Million USD | -14.13% |
2023 Q1 | -4.11 Million USD | -12.52% |
2022 Q3 | -3.52 Million USD | 0.14% |
2022 Q2 | -3.52 Million USD | -64.57% |
2022 Q1 | -2.14 Million USD | -2.73% |
2022 FY | -12.82 Million USD | -94.55% |
2022 Q4 | -3.65 Million USD | -3.92% |
2021 Q2 | -945 Thousand USD | -350.0% |
2021 Q4 | -2.08 Million USD | -75.51% |
2021 Q1 | -210 Thousand USD | 36.56% |
2021 Q3 | -1.18 Million USD | -25.71% |
2021 FY | -6.59 Million USD | -389.09% |
2020 Q1 | -173 Thousand USD | -110.98% |
2020 Q2 | -229 Thousand USD | -32.37% |
2020 Q3 | -335 Thousand USD | -46.29% |
2020 Q4 | -331 Thousand USD | 1.19% |
2020 FY | -1.34 Million USD | -73.26% |
2019 Q4 | 1.57 Million USD | -80.97% |
2019 FY | -778 Thousand USD | -101.82% |
2019 Q2 | 8.3 Million USD | -28.97% |
2019 Q1 | 11.68 Million USD | 12.43% |
2019 Q3 | 8.28 Million USD | -0.2% |
2018 Q1 | 5.98 Million USD | 138.36% |
2018 FY | 42.82 Million USD | 368.36% |
2018 Q2 | 10.44 Million USD | 74.59% |
2018 Q3 | 16 Million USD | 53.21% |
2018 Q4 | 10.39 Million USD | -35.05% |
2017 Q4 | -15.59 Million USD | -582.41% |
2017 Q1 | 196 Thousand USD | -99.52% |
2017 FY | -15.95 Million USD | -129.86% |
2017 Q2 | 1.72 Million USD | 780.61% |
2017 Q3 | -2.28 Million USD | -232.39% |
2016 Q4 | 41.03 Million USD | 900.51% |
2016 Q2 | 4.33 Million USD | 9.19% |
2016 Q1 | 3.97 Million USD | 39.4% |
2016 FY | 53.43 Million USD | 619.4% |
2016 Q3 | 4.1 Million USD | -5.4% |
2015 Q1 | -69 Thousand USD | 95.83% |
2015 FY | 7.42 Million USD | 175.85% |
2015 Q4 | 2.84 Million USD | 14.93% |
2015 Q3 | 2.47 Million USD | 14.14% |
2015 Q2 | 2.17 Million USD | 3246.38% |
2014 Q2 | -3.98 Million USD | 3.25% |
2014 Q3 | -29 Thousand USD | 99.27% |
2014 Q4 | -1.65 Million USD | -5603.45% |
2014 FY | -9.79 Million USD | -33.8% |
2014 Q1 | -4.12 Million USD | -18021.74% |
2013 FY | -7.31 Million USD | 40.02% |
2013 Q3 | -2.95 Million USD | -28.58% |
2013 Q1 | -2.08 Million USD | 52.01% |
2013 Q4 | 23 Thousand USD | 100.78% |
2013 Q2 | -2.29 Million USD | -10.16% |
2012 Q2 | -1.19 Million USD | 66.1% |
2012 Q4 | -4.34 Million USD | -39.35% |
2012 FY | -12.2 Million USD | 80.13% |
2012 Q1 | -3.53 Million USD | 92.9% |
2012 Q3 | -3.12 Million USD | -160.52% |
2011 FY | -61.42 Million USD | -209.27% |
2011 Q1 | -1.55 Million USD | 67.78% |
2011 Q2 | -3 Million USD | -93.69% |
2011 Q3 | -7.1 Million USD | -136.29% |
2011 Q4 | -49.76 Million USD | -600.56% |
2010 FY | -19.86 Million USD | 3.01% |
2010 Q4 | -4.81 Million USD | 35.52% |
2010 Q3 | -7.47 Million USD | -248.74% |
2010 Q1 | -5.43 Million USD | 65.83% |
2010 Q2 | -2.14 Million USD | 60.56% |
2009 FY | -20.47 Million USD | -322.44% |
2009 Q4 | -15.89 Million USD | -193.16% |
2009 Q1 | -722 Thousand USD | -110.42% |
2009 Q2 | 1.56 Million USD | 316.76% |
2009 Q3 | -5.42 Million USD | -446.45% |
2008 Q2 | 1.63 Million USD | 579.71% |
2008 Q4 | 6.92 Million USD | 601.72% |
2008 FY | 9.2 Million USD | 2670.72% |
2008 Q1 | -340.2 Thousand USD | 94.05% |
2008 Q3 | 987 Thousand USD | -39.52% |
2007 Q1 | -1.96 Million USD | 27.28% |
2007 Q3 | 1.78 Million USD | 190.89% |
2007 Q4 | -5.71 Million USD | -420.04% |
2007 Q2 | -1.96 Million USD | 0.0% |
2007 FY | -358.07 Thousand USD | 95.32% |
2006 Q3 | -1.64 Million USD | 24.27% |
2006 FY | -7.64 Million USD | 33.31% |
2006 Q4 | -2.7 Million USD | -64.1% |
2006 Q2 | -2.17 Million USD | 0.0% |
2006 Q1 | -2.17 Million USD | 0.0% |
2005 FY | -11.46 Million USD | 45.27% |
2004 FY | -20.94 Million USD | -65.2% |
2003 FY | -12.68 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
CareCloud, Inc. | -48.67 Million USD | 69.924% |
Augmedix, Inc. | -19.17 Million USD | 23.64% |
BrightSpring Health Services, Inc. Common Stock | -154.6 Million USD | 90.531% |
CareCloud, Inc. | -48.67 Million USD | 69.924% |
HealthEquity, Inc. | 55.71 Million USD | 126.276% |
iCoreConnect Inc. | -15.55 Million USD | 5.869% |
Inovalon Holdings, Inc. | 22.57 Million USD | 164.835% |
Nutex Health, Inc. | -45.78 Million USD | 68.028% |
Omnicell, Inc. | -20.37 Million USD | 28.138% |
OneMedNet Corporation | -23.2 Million USD | 36.916% |
Progyny, Inc. | 62.03 Million USD | 123.597% |
Renalytix Plc | -33.45 Million USD | 56.244% |
Schrödinger, Inc. | 40.72 Million USD | 135.95% |
Simulations Plus, Inc. | 9.95 Million USD | 247.067% |
SOPHiA GENETICS SA | -78.98 Million USD | 81.465% |
Streamline Health Solutions, Inc. | -18.69 Million USD | 21.704% |
Ontrak, Inc. | -27.92 Million USD | 47.568% |
GE HealthCare Technologies Inc. | 1.56 Billion USD | 100.934% |
Sharecare, Inc. | -128.49 Million USD | 88.608% |
Aclarion, Inc. | -4.91 Million USD | -198.063% |
CareMax, Inc. | -683.34 Million USD | 97.858% |
Bullfrog AI Holdings, Inc. Common Stock | -5.35 Million USD | -173.326% |
Forian Inc. | 11.1 Million USD | 231.803% |
Bullfrog AI Holdings, Inc. Warrants | -5.35 Million USD | -173.326% |
GeneDx Holdings Corp. | -175.76 Million USD | 91.671% |
SCWorx Corp. | -3.98 Million USD | -267.708% |
Minerva Surgical, Inc. | -34.11 Million USD | 57.085% |
Definitive Healthcare Corp. | -202.38 Million USD | 92.767% |
10x Genomics, Inc. | -255.09 Million USD | 94.261% |
Zhongchao Inc. | -11.33 Million USD | -29.138% |
Accolade, Inc. | -99.8 Million USD | 85.332% |
MSP Recovery, Inc. | -56.34 Million USD | 74.02% |
R1 RCM Inc. | 3.3 Million USD | 543.606% |
Spok Holdings, Inc. | 15.66 Million USD | 193.444% |
Privia Health Group, Inc. | 23.07 Million USD | 163.43% |
EUDA Health Holdings Limited | -10.03 Million USD | -45.814% |
TruBridge, Inc. | -45.78 Million USD | 68.029% |
BrightSpring Health Services, Inc. Tangible Equity Unit | -154.6 Million USD | 90.531% |
Sharecare, Inc. | -128.49 Million USD | 88.608% |
Health Catalyst, Inc. | -118.14 Million USD | 87.61% |
GoodRx Holdings, Inc. | -8.86 Million USD | -65.077% |
Premier, Inc. | 119.54 Million USD | 112.246% |
HealthStream, Inc. | 15.21 Million USD | 196.227% |
Certara, Inc. | -55.35 Million USD | 73.555% |
GeneDx Holdings Corp. | -175.76 Million USD | 91.671% |
Ontrak, Inc. | -27.92 Million USD | 47.568% |
SHL Telemedicine Ltd. | -7.05 Million USD | -107.469% |
CareCloud, Inc. | -48.67 Million USD | 69.924% |
EUDA Health Holdings Limited | -10.03 Million USD | -45.814% |
HeartBeam, Inc. | -14.63 Million USD | -0.0% |
Mangoceuticals, Inc. | -9.21 Million USD | -58.905% |
CareMax, Inc. | -683.34 Million USD | 97.858% |
Healthcare Triangle, Inc. | -12.33 Million USD | -18.64% |
National Research Corporation | 30.97 Million USD | 147.267% |
Aclarion, Inc. | -4.91 Million USD | -198.063% |
OptimizeRx Corporation | -17.56 Million USD | 16.662% |